Analysts think CORT stock price could increase by 150%
Feb 07, 2026, 12:25 PM
-16.61%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
7 analysts think CORT stock price will increase by 149.94%. The current median analyst target is $102.00 compared to a current stock price of $40.81. The lowest analysts target is $50.50 and the highest analyst target is $127.05.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.